WellPoint, American Academy of Pediatrics Pen Deal (revised) - Analyst Blog

By
A A A

WellPoint Inc. ( WLP ) has been working toward increasing awareness among the masses about child health.  For this, the company has collaborated with The American Academy of Pediatrics - an organization that has 60,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists.

Per the alliance, the American Academy of Pediatrics and WellPoint will chalk out a series that will educate physicians -- specifically designed for pediatricians -- on pediatric health issues like childhood obesity, asthma and behavioral concerns. Moreover, the united body will emphasize on the significance of child well visits and immunizations in this program. These Pediatric Learning Collaboratives will be presented via webinars for providers through 2014.

WellPoint is one of the leading health benefits companies in America and serves nearly 68 million people through its subsidiaries. The aforementioned collaboration is expected to create awareness among providers and clarify queries regarding pediatric health among individuals and thus help WellPoint improve its efforts toward greater provider collaboration and gain clients.

In other words, this program will not only educate physicians about child health but will also open up avenues for WellPoint to generate additional support from the provider world, in tandem with increased membership and revenues. The long-term growth rate for this stock is 10.2%.

WellPoint has been actively collaborating with companies to enhance its services. Earlier this month, it collaborated with Healthways Inc. ( HWAY ) to offer its affiliated health plan members an access to Dr. Dean Ornish Program for Heart Disease. With the provision of this new program WellPoint aims to deliver enhanced services to its members and tap market opportunities.

WellPoint currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the healthcare sector include Aetna Inc. ( AET ) and LCA-Vision Inc. ( LCAV ). While LCA-Vision carries a Zacks Rank #1 (Strong Buy), Aetna holds a Zacks Rank #2 (Buy).

(We are re-issuing this blog to correct an incorrect connotation. The original article, published Friday, February 28, 2014 should no longer be relied upon.)

AETNA INC-NEW (AET): Free Stock Analysis Report

HEALTHWAYS INC (HWAY): Free Stock Analysis Report

LCA-VISION INC (LCAV): Free Stock Analysis Report

WELLPOINT INC (WLP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: AET , HWAY , LCAV , WLP

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

89,070,840
  • $17.26 ▲ 3.23%
78,931,485
  • $7.02 ▲ 4.46%
77,555,734
  • $6.70 ▲ 6.69%
77,025,346
  • $24.66 ▲ 0.69%
74,713,335
  • $101.80 ▲ 1.82%
72,324,726
  • $7.64 ▲ 0.79%
57,112,188
  • $17.84 ▲ 55.27%
53,321,397
  • $18.01 ▼ 4.46%
As of 12/17/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com